Vitamin D status and cardiovascular outcome.
Federica SaponaroC MarcocciR ZucchiPublished in: Journal of endocrinological investigation (2019)
Calcitriol or 1,25(OH)2D, the active hormone, binds to the specific nuclear receptor VDR, which is expressed in rat and human heart and vasculature and has effects on myocardiocytes, smooth cells, and endothelial cells. 25-Hydroxy-vitamin D (25OHD) represents the biomarker of vitamin D levels and reflects vitamin D status. There is consistent evidence that low serum 25OHD levels are associated with increased risk of cardiovascular diseases, including hypertension, coronary artery disease, ischemic heart disease, heart failure, stroke, and type 2 diabetes. Randomized-controlled trials and Mendelian randomization studies so far have not succeeded in proving a benefit of vitamin D supplementation. However, the latter investigations are affected by some methodological limitations, and therefore, it is still unclear if vitamin D deficiency has a causative role in cardiovascular diseases or is rather a marker of poor health in chronic disease.
Keyphrases
- endothelial cells
- cardiovascular disease
- heart failure
- type diabetes
- coronary artery disease
- atrial fibrillation
- induced apoptosis
- randomized controlled trial
- blood pressure
- healthcare
- public health
- oxidative stress
- high glucose
- cardiovascular events
- cardiovascular risk factors
- mental health
- percutaneous coronary intervention
- cell cycle arrest
- induced pluripotent stem cells
- vascular endothelial growth factor
- glycemic control
- coronary artery bypass grafting
- clinical trial
- cell death
- signaling pathway
- study protocol
- acute heart failure
- brain injury
- transcatheter aortic valve replacement